Haematology
1. Economic evaluation of the use of prophylactic clodronate to treat multiple myeloma.
Presented at the EORTC First European Conference on the Economics of Cancer, Brussels, November 1997 and published in European Journal of Cancer 1997; 33(Suppl 9): S25.
2. The annual cost of blood transfusions in the United Kingdom.
Author: JF Guest, V Munro & RF Cookson.
Source: Clinical & Laboratory Haematology 1998; 20, 111-118.
3. Economic impact of using clodronate in the management of patients with multiple myeloma.
Presented at the 38th Meeting of the British Society for Haematology, Glasgow, April 1998 and at the ISH-EHA Combined Haematology Congress, Amsterdam, July 1998.
4. Cost-effectiveness of amphotericin B plus G-CSF compared to amphotericin B in the treatment of a presumed deep-seated fungal infection in neutropenic patients in the UK.
Author: TN Flynn, SM Kelsey, DL Hazel & JF Guest.
Source: Blood 1998; 92(10) Suppl 1 (part 2 of 2): Abstract no: 3746.
5. Cost-effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.
Author: TN Flynn, SM Kelsey, DL Hazel & JF Guest.
Source: PharmacoEconomics 1999; 16(5,2): 543-550
6. Economic impact of using clodronate in the management of patients with multiple myeloma.
Author: NJ Bruce, EV McCloskey, JA Kanis & JF Guest.
Source: British Journal of Haematology 1999; 104: 358-364.
7. The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma.
Author: EV McCloskey, JF Guest & JA Kanis.
Source: Drugs 2001; 61 (9): 1253-1274
8. The increasing cost of blood transfusions in the UK.
Presented at the American Society for Hematology Annual Meeting, Philadelphia, December 2002 and published in Blood 2002; 100(11): 289a. Abstract 1109.
9. The annual cost of blood transfusions in the UK.
Author: SJ Varney & JF Guest.
Source: Transfusion Medicine 2003; 13: 205-218
10. The annual cost to society of blood transfusions in the UK.
Presented at the 8th Congress of the European Hematology Association, Lyon, June 2003 and published in The Hematology Journal 2003; 4(Suppl 2): 243, Abstract 816.
<<< Go Back